Lithothamnion (Aquamin) and joints

What 2 graded rows on lithothamnion (aquamin) agree on for joints, and where they differ. Counted side by side, never averaged.

Consensus finder Rows from the Lithothamnion (Aquamin) page, reviewed Oct 21, 2026 How it decides

What the rows agree on

Each block and row is one graded row from the Lithothamnion (Aquamin) page, with its PubMed record.

Supplement

Lithothamnion (Aquamin) Choose another

2 rows · 99 people

Inconsistent: both rows reported mixed results.

Mixed

Improved

Each block is one evidence row, sized by how many people it enrolled, with its grade inside. Outlined: mixed results.

From the rows

The best-graded row, grade D, is a randomized trial of 70 people (2008) and reported mixed results.

Each row reported mixed results on its own, so there is no side to compare. The rows enrolled 29 to 70 people and were published from 2008 to 2009.

2 mixed

Grade DKnee osteoarthritis pain and walking distance · Mixed
RCT · n 70 · 2008 · Adults with moderate to severe knee osteoarthritis (50 completed)
2,400 mg Aquamin a day · 12 weeks
Pain score changes differed between groups (p = 0.009), but groups differed at baseline. Within the Aquamin group pain and stiffness improved and walking distance rose by 101 feet (7%); the Aquamin plus glucosamine group did not improve.
Row on the Lithothamnion (Aquamin) page · PubMed 18279523 (opens PubMed)
Grade DKnee osteoarthritis during NSAID reduction · Mixed
RCT · n 29 · 2009 · Adults with moderate to severe knee osteoarthritis (22 treated, 14 completed)
2,400 mg a day · Up to 12 weeks
WOMAC scores did not differ from placebo; knee range of motion and 6-minute walking distance (difference 136 feet) improved vs placebo during a 50% cut in NSAID use.
Row on the Lithothamnion (Aquamin) page · PubMed 19187557 (opens PubMed)